Skip to main content

Table 2 Donor and transplant characteristics by ECD status

From: The Canadian experience using the expanded criteria donor classification for allocating deceased donor kidneys for transplantation

 

Total N = 1422

ECD n = 325

Non-ECD n = 1097

p value

Donor characteristics

    

Age at time of death, years

    

 Mean (SD)

47 (14)

63 (6)

42 (12)

<0.001

 <50 years

729 (51 %)

0

729 (66 %)

<0.001

 50 to 59 years

433 (30 %)

65 (20 %)

368 (34 %)

 ≥60 years

260 (18 %)

260 (80 %)

0

Women

616 (43 %)

152 (47 %)

464 (42 %)

0.153

Body mass index (kg/m2)

    

 Mean (SD)

27.2 (5.7)

28.5 (4.9)

26.8 (5.9)

<0.001

Pre-terminal serum creatinine, μmol/L

    

 Median (Q1–Q3)

66 (53-83)

68 (54-87)

66 (53-82)

<0.001

Pre-terminal eGFR, mL/min

    

 Median (Q1–Q3)

99 (77–127)

84 (68–110)

102 (81–130)

<0.001

Cause of death

    

 Cerebrovascular accident

172 (12 %)

71 (22 %)

101 (9 %)

<0.001

 Trauma

119 (8 %)

23 (7 %)

96 (9 %)

 Other

1131 (80 %)

231 (71 %)

900 (82 %)

Past medical history

    

 Diabetes mellitus

147 (10 %)

68 (21 %)

87 (8 %)

<0.001

 Hyperlipidemia

33 (2 %)

11 (3 %)

26 (2 %)

0.147

 Hypertension

518 (36 %)

223 (69 %)

295 (27 %)

<0.001

Donation after circulatory death

205 (14)

22 (7 %)

183 (17 %)

<0.001

Transplant Characteristics

    

Year of transplant

    

 2005

150 (11 %)

33 (10 %)

117 (11 %)

0.414

 2006

208 (15 %)

44 (14 %)

164 (15 %)

 2007

241 (17 %)

54 (17 %)

187 (17 %)

 2008

213 (15 %)

52 (16 %)

161 (15 %)

 2009

278 (20 %)

64 (20 %)

214 (20 %)

 2010

266 (19 %)

57 (18 %)

209 (19 %)

 2011 (until March 31)

66 (5 %)

21 (6 %)

45 (4 %)

HLA mismatch (max 6)

    

 0

16 (1 %)

≤5

16 (1 %)

0.269

 1

32 (2 %)

9 (3 %)

23 (2 %)

 2

62 (4 %)

17 (5 %)

45 (4 %)

 3

127 (9 %)

28 (9 %)

99 (9 %)

 4

300 (21 %)

61 (19 %)

239 (22 %)

 5

598 (42 %)

135 (42 %)

463 (42 %)

 6

287 (20 %)

75 (23 %)

212 (19 %)

Pulsatile perfusion pump use

275 (19 %)

111 (34 %)

164 (15 %)

<0.001

Cold ischemia time, minutes

    

 Median (Q1–Q3)

691 (579–813)

691 (574–772)

691 (580–829)

0.098

  1. Cells with ≤5 observations were suppressed to prevent indirect identification of individuals
  2. HLA human leukocyte antigen